In CLL cells, CD38 expression, which works in synergy with the BCR/CD19 complex, is associated with greater proliferative and antiapoptotic activity as well as with enhanced migratory ability [177,178,179]. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.